Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May;39(5):543-556.
doi: 10.14670/HH-18-689. Epub 2023 Dec 13.

Natural products and synthetic analogs as selective orphan nuclear receptor 4A (NR4A) modulators

Stephen Safe  1
Affiliations
Review

Natural products and synthetic analogs as selective orphan nuclear receptor 4A (NR4A) modulators

Stephen Safe. Histol Histopathol. 2024 May.

Abstract

Although endogenous ligands for the orphan nuclear receptor 4A1 (NR4A1, Nur77), NR4A2 (Nurr1), and NR4A3 (Nor-1) have not been identified, several natural products and synthetic analogs bind NR4A members. These studies are becoming increasingly important since members of the NR4A subfamily of 3 receptors are potential drug targets for treating cancer and non-cancer endpoints and particularly those conditions associated with inflammatory diseases. Ligands that bind NR4A1, NR4A2, and NR4A3 including Cytosporone B, celastrol, bis-indole derived (CDIM) compounds, tryptophan/indolic, metabolites, prostaglandins, resveratrol, piperlongumine, fatty acids, flavonoids, alkaloids, peptides, and drug families including statins and antimalarial drugs. The structural diversity of NR4A ligands and their overlapping and unique effects on NR4A1, NR4A2, and NR4A3 suggest that NR4A ligands are selective NR4A modulators (SNR4AMs) that exhibit tissue-, structure-, and response-specific activities. The SNR4AM activities of NR4A ligands are exemplified among the Cytosporone B analogs where n-pentyl-2-[3,5-dihydroxy-2-(nonanoyl)]phenyl acetate (PDNPA) binds NR4A1, NR4A2 and NR4A3 but activates only NR4A1 and exhibits significant functional differences with other Cytosporone B analogs. The number of potential clinical applications of agents targeting NR4A is increasing and this should spur future development of SNR4AMs as therapeutics that act through NR4A1, NR4A2 and NR4A3.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Ao M., Zhang J., Qian Y., Li B., Wang X., Chen J., Zhang Y., Cao Y., Qiu Y., Xu Y., Wu Z. and Fang M. (2022). Design and synthesis of adamantyl-substituted flavonoid derivatives as anti- inflammatory Nur77 modulators: Compound B7 targets Nur77 and improves LPS- induced inflammation in vitro and in vivo. Bioorg. Chem. 120, 105645. - PubMed
    1. Beard J.A., Tenga A. and Chen T. (2015). The interplay of NR4A receptors and the oncogene- tumor suppressor networks in cancer. Cell. Signal. 27, 257-266. - PMC - PubMed
    1. Bedi S., Hines G.V., Lozada-Fernandez V.V., de Jesus Piva C., Kaliappan A., Rider S.D. Jr. and Hostetler H.A. (2017). Fatty acid binding profile of the liver X receptor α. J. Lipid Res. 58, 393-402. - PMC - PubMed
    1. Bonta P.I., van Tiel C.M., Vos M., Pols T.W., van Thienen J.V., Ferreira V., Arkenbout E.K., Seppen J., Spek C.A., van der Poll T., Pannekoek H. and de Vries C.J. (2006). Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler. Thromb. Vasc. Biol. 26, 2288-2294. - PubMed
    1. Bookout A.L., Jeong Y., Downes M., Yu R.T., Evans R.M. and Mangelsdorf D.J. (2006). Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126, 789-799. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources

-